BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PALYNZIQ (Pegvaliase) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PALYNZIQ (Pegvaliase)\, from ClinicalTria
 ls.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07477691-10778@assetmemo.bio
DTSTAMP:20261121T004029Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:PALYNZIQ (Pegvaliase): Phase 4 readout est. (NCT07477691)
DESCRIPTION:PALYNZIQ (Pegvaliase)\, phase 4\, Phenylketonuria.\nStudy: Immu
 ne Modulation During Palynziq® Treatment in Adults (IMPALA)\nEstimated pr
 imary completion: 30 September 2027. This is a ClinicalTrials.gov estimate
 \, not a confirmed readout date\, and it can move.\nDrug page: https://ass
 etmemo.bio/drug/pegvaliase#upcoming-events\nRegistry record: https://clini
 caltrials.gov/study/NCT07477691
URL:https://assetmemo.bio/drug/pegvaliase#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
